Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Nov;19(6):616-25.
doi: 10.1097/MCP.0b013e328365ab89.

Treatment strategies for complex behavioral insomnia in children with neurodevelopmental disorders

Affiliations
Review

Treatment strategies for complex behavioral insomnia in children with neurodevelopmental disorders

Madeleine Grigg-Damberger et al. Curr Opin Pulm Med. 2013 Nov.

Abstract

Purpose of review: This review describes recent research in pediatric behavioral insomnias in neurodevelopmental disorders and their treatment.

Recent findings: Insomnia in children with autism spectrum disorder (ASD) and other neurodevelopmental disorders (NDDs) is typically complex, chronic, and difficult to adequately control. Abnormalities in genetic and/or epigenetic regulation of sleep/wakefulness and its timing predispose patients with NDD to insomnia, although poor sleep hygiene, maladaptive associations, and limit-setting are likely to contribute. Parents are agents for change in problematic sleep behaviors in patients with NDD. We review the benefits of behavioral therapies and melatonin to treat sleep problems in children with NDD. Problematic sleep is so prevalent in some neurodevelopmental syndromes (Rett, Angelman, Williams, and Smith-Magenis) that it is part of their diagnostic criteria.

Summary: Children and adolescents with neurological disorders frequently have complex sleep disorders that require treatment. Understanding the basic pathology and treatment strategies provides an opportunity to improve well being and quality of life in those affected by NDD and their families.

PubMed Disclaimer

MeSH terms

Substances